Badih Elmunzer is a Gastroenterology physician affiliated with Medical University of South Carolina. OpenAlex indexes 60 publications with 630 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
85.3%Proton pump inhibitor72.7%Pantoprazole Sodium46%Omeprazole34%Esomeprazole Magnesium20%Part D<11 patientsAntidiarrheal microorganisms12.6%Creon100%Part D<11 patientsDermatology
14.7%Polyene Antifungal14.7%Nystatin100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2015–2020 per NIH RePORTER. The latest:
- Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial
Medical University of South Carolina
FY2020$1,499,999U01DK104833 - Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial
Medical University of South Carolina
FY2019$1,770,531U01DK104833 - Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial
Medical University of South Carolina
FY2019$353,963U01DK104833
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Jacobo Mintzer, MD
Medical University of South Carolina
Marc Chimowitz, MD
Medical University of South Carolina
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”